Moleculin Biotech Files 8-K
Ticker: MBRX · Form: 8-K · Filed: Jun 4, 2025 · CIK: 1659617
Sentiment: neutral
Topics: disclosure, financials
TL;DR
Moleculin Biotech dropped an 8-K on June 4th, check it for updates.
AI Summary
Moleculin Biotech, Inc. filed an 8-K on June 4, 2025, reporting on events that occurred on the same date. The filing includes financial statements and exhibits, and is related to Regulation FD Disclosure and Other Events. The company is incorporated in Delaware and headquartered in Houston, Texas.
Why It Matters
This filing provides important updates and disclosures from Moleculin Biotech, Inc. to investors and the public regarding recent events and financial information.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for corporate disclosures and does not appear to contain significant negative news.
Key Players & Entities
- Moleculin Biotech, Inc. (company) — Registrant
- June 4, 2025 (date) — Date of Report
- Houston, TX (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Regulation FD Disclosure, Other Events, and to include Financial Statements and Exhibits as of June 4, 2025.
When was this 8-K report filed?
This 8-K report was filed on June 4, 2025.
What is Moleculin Biotech, Inc.'s principal executive office address?
Moleculin Biotech, Inc.'s principal executive offices are located at 5300 Memorial Drive, Suite 950, Houston, TX 77007.
What is the company's telephone number?
The company's telephone number is (713) 300-5160.
What is the Commission File Number for Moleculin Biotech, Inc.?
The Commission File Number for Moleculin Biotech, Inc. is 001-37758.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 4, 2025 regarding Moleculin Biotech, Inc. (MBRX).